Delivery Order SPE2DB22D2108-SPE2DB25FU5NK
- Not listed
- The Defense Logistics Agency (DLA) awarded a $5,155.59 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Imitrex 6 mg/0.5 mL cartridges (0.5 mL units). This firm fixed-price contract represents a non-competitive delivery order with an ultimate completion date of August 11, 2025, and will be performed at the company's corporate office in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $12,487.60 to AmerisourceBergen Drug Corp for Imitrex 6 mg/0.5 ml cartridges on July 22, 2025, with completion targeted for July 23, 2025. This firm fixed-price contract represents a non-set-aside award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Imitrex is a migraine treatment medication, and this delivery order fulfills specific pharmaceutical supply needs for federal healthcare...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,107.71 to AmerisourceBergen Drug Corp for the supply of Imitrex 6 mg/0.5 mL cartridges on August 18, 2025, with a completion date of August 19, 2025. This firm fixed price delivery order represents a continuation of pharmaceutical supply support to federal medical procurement needs, specifically supporting military and veteran healthcare systems. The award was made through open competition with no set-aside designation,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $22,521.52, is for the supply of Imitrex 6 mg/0.5 ml cartridges to support federal healthcare programs. The contract has a firm fixed price and an ultimate completion date of September 10, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Imitrex 6 mg/0.5 ml cartridges valued at $20,917.11. This firm fixed-price delivery order is scheduled for completion by August 5, 2025, and will be fulfilled from the contractor's location in Conshohocken, Pennsylvania. The award utilized no set-aside designation, indicating it was competitively awarded through open competition. This delivery order is executed as a child...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $4,833.90 firm fixed-price contract is for Imitrex 6 mg/0.5 ml cartridges 0.5 ml, with a completion date of November 8, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of IMITREX 6 MG/0.5 ML CARTRIDGES 0.5ML. The contract has a ceiling value of $3,266.90 and a period of performance through November 20, 2024. The contract is a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Imitrex 6 mg/0.5 ml cartridges. The contract has a firm fixed price of $12,124.38 and a completion date of March 7, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which serves as the primary vehicle for...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of IMITREX 6 MG/0.5 ML CARTRIDGES 0.5ML. The firm-fixed-price contract has a ceiling value of $3,877.00 and an ultimate completion date of January 27, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Imitrex 6 mg/0.5 ml cartridges, a medication used to treat migraines. The contract has a firm fixed price of $10,321.41 and a period of performance extending through April 17, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- SPE2DB22D2108Indefinite Delivery Contract
- SPE2DB22D2108-SPE2DB25FU5NKDelivery Order
This delivery order, awarded on August 20, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides Imitrex 6 mg/0.5 ml cartridges with a ceiling value of $9,023.44 under a firm fixed price arrangement. The order is scheduled for completion by August 21, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a single transaction within AmerisourceBergen's broader pharmaceutical supply portfolio to the federal government. This contract is a child delivery order under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor, AmerisourceBergen serves critical federal medical procurement needs across military and veteran healthcare systems. The Imitrex order supports the Defense Health Agency and other government healthcare customers through the company's comprehensive global pharmaceutical support vehicle, enabling the provision of brand-name medications, generic drugs, and specialized medical supplies across multiple therapeutic domains to military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.0k | 8/20/25 |